---
title: Worldwide analysis of actionable genomic alterations in lung cancer and targeted
  pharmacogenomic strategies
date: '2024-09-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39296198/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240919194323&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Based on data from the Global Cancer Statistics 2022, lung cancer stands
  as the most lethal cancer worldwide, with age-adjusted incidence and mortality rates
  of 23.6 and 16.9 per 100,000 people, respectively. Despite significant strides in
  precision oncology driven by large-scale international research consortia, there
  remains a critical need to deepen our understanding of the genomic landscape across
  diverse racial and ethnic groups. To address this challenge, we performed comprehensive
  ...
disable_comments: true
---
Based on data from the Global Cancer Statistics 2022, lung cancer stands as the most lethal cancer worldwide, with age-adjusted incidence and mortality rates of 23.6 and 16.9 per 100,000 people, respectively. Despite significant strides in precision oncology driven by large-scale international research consortia, there remains a critical need to deepen our understanding of the genomic landscape across diverse racial and ethnic groups. To address this challenge, we performed comprehensive ...